The inhibitory effects of hydrogen sulfide on pacemaker activity of interstitial cells of cajal from mouse small intestine.
In this study, we studied whether hydrogen sulfide (H(2)S) has an effect on the pacemaker activity of interstitial cells of Cajal (ICC), in the small intestine of mice. The actions of H(2)S on pacemaker activity were investigated using whole-cell patch-clamp technique, intracellular Ca(2+) analysis at 30 and RT-PCR in cultured mouse intestinal ICC. Exogenously applied sodium hydrogen sulfide (NaHS), a donor of hydrogen sulfide, caused a slight tonic inward current on pacemaker activity in ICC at low concentrations (50 and 100 microM), but at high concentration (500 microM and 1 mM) it seemed to cause light tonic inward currents and then inhibited pacemaker amplitude and pacemaker frequency, and also an increase in the resting currents in the outward direction. Glibenclamide or other potassium channel blockers (TEA, BaCl(2), apamin or 4-aminopydirine) did not have an effect on NaHS-induced action in ICC. The exogenous application of carbonilcyanide p-triflouromethoxyphenylhydrazone (FCCP) and thapsigargin also inhibited the pacemaker activity of ICC as NaHS. Also, we found NaHS inhibited the spontaneous intracellular Ca(2+) ([Ca(2+)](i)) oscillations in cultured ICC. In doing an RT-PCR experiment, we found that ICC enriched population lacked mRNA for both CSE and CBS, but was prominently detected in unsorted muscle. In conclusion, H(2)S inhibited the pacemaker activity of ICC by modulating intracellular Ca(2+). These results can serve as evidence of the physiological action of H(2)S as acting on the ICC in gastrointestinal (GI) motility.
Parajuli
Shankar Prasad
SP
Department of Physiology, College of Medicine, Chosun University, Gwangju 501-759, Korea.
Choi
Seok
S
Lee
Jun
J
Kim
Young Dae
YD
Park
Chan Guk
CG
Kim
Man Yoo
MY
Kim
Hyun Il
HI
Yeum
Cheol Ho
CH
Jun
Jae Yeoul
JY
Biochem Pharmacol. 1989 Mar 15;38(6):973-81
2930598
J Neurosci. 1996 Feb 1;16(3):1066-71
8558235
Annu Rev Pharmacol Toxicol. 1992;32:109-34
1605565
J Physiol. 2000 Jun 1;525 Pt 2:355-61
10835039
Biochem J. 1990 Jul 15;269(2):335-40
2201285
Br J Pharmacol. 2004 May;142(1):31-4
15051627
Curr Pharm Des. 2005;11(15):1915-40
15974968
J Nutr. 1999 May;129(5):928-33
10222381
Biochem Biophys Res Commun. 1997 Aug 28;237(3):527-31
9299397
Br J Pharmacol. 2005 Apr;144(8):1126-37
15700022
J Chromatogr. 1990 Apr 6;526(2):540-5
2361993
Neurogastroenterol Motil. 2008 Dec;20(12):1306-16
19019033
Gastroenterology. 2006 Jul;131(1):259-71
16831608
J Physiol. 2001 May 15;533(Pt 1):155-63
11351024
J Anal Toxicol. 1989 Mar-Apr;13(2):105-9
2733387
J Physiol. 2000 May 15;525 Pt 1:105-11
10811729
Toxicology. 2007 Mar 22;232(1-2):138-46
17276573
Cell Physiol Biochem. 2006;18(4-5):187-98
17167224
Am J Physiol. 1995 Dec;269(6 Pt 1):C1577-85
8572188
Eur J Pharmacol. 2004 Jul 8;495(1):35-42
15219818
EMBO J. 2001 Nov 1;20(21):6008-16
11689441
Protein Expr Purif. 1994 Oct;5(5):442-8
7827502